Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)

Clinical trial NCT01303406 · COMPLETED

Trial details

NCT number: NCT01303406
Sponsor: Santhera Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Friedreich's Ataxia

Start date: 2011-04-01
Primary completion: 2012-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.